Progress on the studies of cyclic lipopeptides.
- Author:
Jin-shan TANG
1
;
Hao GAO
;
Yi DAI
;
Kui HONG
;
Xin-sheng YAO
Author Information
1. School of Traditional Chinese Materia Medica, Shenyang Pharmnaceutical University, Shenyang 110016, China.
- Publication Type:Journal Article
- MeSH:
Anti-Bacterial Agents;
pharmacology;
Antibiotics, Antineoplastic;
pharmacology;
Bacillus;
chemistry;
Cyanobacteria;
chemistry;
Daptomycin;
isolation & purification;
pharmacology;
Humans;
Lipopeptides;
chemistry;
isolation & purification;
pharmacology;
Peptides, Cyclic;
chemistry;
isolation & purification;
pharmacology;
Pseudomonas;
chemistry
- From:
Acta Pharmaceutica Sinica
2008;43(9):873-883
- CountryChina
- Language:Chinese
-
Abstract:
Cyclic lipopeptide, also named as acylpeptide, which was characteristic with novel structures, was paid more attention in the recent years. Cyclic lipopeptide showed various bioactivities including antibacterial, anti-tumor, anti-inflammatory, etc. Cyclic lipopeptide originated mainly from the second metabolites of microorganism, such as Cyanobacterium, Bacterium, Actinomyces, etc. The bacteria included the genus of Bacillus and Pseudomonas. In this account, the review has been made on the development of cyclic lipopeptide.
